Clinical trial
Riboflavin for Glutamate Reduction in Alcohol Withdrawal
NCT04232800 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Riboflavin for Glutamate Reduction in Alcohol Withdrawal
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- December 1, 2021
- Completion date
- October 25, 2022
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder, alcohol withdrawal, nutrition disorders